Apply Give

Other ways to search: Events Calendar | UTHSC

UTHSC-led team receives $3.16 million from National Cancer Institute for cancer immunotherapy drug development

Written by Communications and Marketing

|

A UTHSC-led team has received $3.16 million from the National Cancer Institute to develop a drug that boosts the immune system response in cancer patients to destroy tumor cells. Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in the Department of Physiology, is the lead investigator. Sue Chin Lee, PhD, associate professor in the same department, is a principal investigator.

Top Publishers